Clinical Trials

NCT03713125 | ENROLLING_BY_INVITATION | NA
260 participants

Executive Function in Early Childhood

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2019-08-13
Completion:
2029-07-31
Conditions
  • Reading Disability
Interventions
  • BEHAVIORAL
No Results Yet
NCT03412877 | RECRUITING | PHASE2
285 participants

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2018-09-06
Completion:
2028-03-23
Conditions
  • Endocrine Tumors
  • Non-Small Cell Lung Cancer
  • Ovarian Cancer
  • Breast Cancer
  • Gastrointestinal/Genitourinary Cancers
  • Neuroendocrine Tumors
  • Multiple Myeloma
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT02506153 | ACTIVE_NOT_RECRUITING | PHASE3
1301 participants

Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2015-11-10
Completion:
2023-09-15
Conditions
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Cutaneous Melanoma
  • Metastatic Mucosal Melanoma
  • Metastatic Non-Cutaneous Melanoma
  • Non-Cutaneous Melanoma
  • Recurrent Cutaneous Melanoma
  • Recurrent Mucosal Melanoma
  • Recurrent Non-Cutaneous Melanoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page